Cargando…

Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future

The estrogen receptor (ER) is a classical receptor protein that plays a crucial role in mediating multiple signaling pathways in various target organs. It has been shown that ER-targeting therapies inhibit breast cancer cell proliferation, enhance neuronal protection, and promote osteoclast formatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Jiaqi, Tao, Yiran, Hu, Zelin, Li, Junjie, Xue, Ziyi, Zhang, Ya, Lei, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551544/ https://www.ncbi.nlm.nih.gov/pubmed/37808197 http://dx.doi.org/10.3389/fphar.2023.1225951

Ejemplares similares

Targeting the formation of estrogens for treatment of hormone dependent diseases–current status
por: Rižner, Tea Lanišnik, et al.
Publicado: (2023)

Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction
por: Ross, Sandra L., et al.
Publicado: (2017)

Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions
por: Spisni, Enzo, et al.
Publicado: (2022)

In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B(2) Receptor Antagonist
por: Lesage, Anne, et al.
Publicado: (2020)

Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges
por: Gan, Lu, et al.
Publicado: (2022)

Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives
por: Zulfiqar, Bilal, et al.
Publicado: (2022)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
por: Ghallab, Alaa M., et al.
Publicado: (2022)

Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression
por: Yu, Ming, et al.
Publicado: (2022)

The Pathological Mechanisms of Estrogen-Induced Cholestasis: Current Perspectives
por: Zu, Yue, et al.
Publicado: (2021)

Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
por: Sarkar, Chandan, et al.
Publicado: (2020)

Update on Novel Non-Operative Treatment for Osteoarthritis: Current Status and Future Trends
por: Chen, Tao, et al.
Publicado: (2021)

Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care breast cancer endocrine therapies and a selective estrogen receptor agonist and antagonist
por: Olayoku, Folasade R., et al.
Publicado: (2023)

Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
por: Liu, Wenliang, et al.
Publicado: (2022)

A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance
por: Ma, Yongxian, et al.
Publicado: (2015)

Patient-reported outcomes labeling for oncology drugs: Multidisciplinary perspectives on current status and future directions
por: Cella, David, et al.
Publicado: (2022)

Estrogen-Related Receptor γ Induces Angiogenesis and Extracellular Matrix Degradation of Temporomandibular Joint Osteoarthritis in Rats
por: Zhao, Haoming, et al.
Publicado: (2019)

Platelets and platelet extracellular vesicles in drug delivery therapy: A review of the current status and future prospects
por: Dai, Zhanqiu, et al.
Publicado: (2022)

Current status of immunotherapy for non-small cell lung cancer
por: Yang, Tao, et al.
Publicado: (2022)

Recent developments in nucleic acid-based therapies for Parkinson’s disease: Current status, clinical potential, and future strategies
por: Pandey, Shivam Kumar, et al.
Publicado: (2022)

An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
por: Ye, Qingmei, et al.
Publicado: (2023)

Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease
por: Wu, Yichuan, et al.
Publicado: (2022)

Editorial: Food/Diet Supplements From Natural Sources: Current Status and Future Challenges From a Pharmacological Perspective
por: Tomczyk, Michał, et al.
Publicado: (2021)

Current status and future promise of next-generation poly (ADP-Ribose) polymerase 1-selective inhibitor AZD5305
por: Zheng, Jingcao, et al.
Publicado: (2023)

Rhoifolin Alleviates Alcoholic Liver Disease In Vivo and In Vitro via Inhibition of the TLR4/NF-κB Signaling Pathway
por: Mai, Baoyu, et al.
Publicado: (2022)

The effects of metformin in the treatment of osteoarthritis: Current perspectives
por: Song, Yanhong, et al.
Publicado: (2022)

Gallbladder cancer: current and future treatment options
por: Zhou, Yanzhao, et al.
Publicado: (2023)

Combined inhibition of PARP and EZH2 for cancer treatment: Current status, opportunities, and challenges
por: Zhang, Xi, et al.
Publicado: (2022)

Current State and Future Prospects of Direct-to-Consumer Pharmacogenetics
por: Chua, E. W., et al.
Publicado: (2012)

Traditional medicines and globalization: current and future perspectives in ethnopharmacology
por: Leonti, Marco, et al.
Publicado: (2013)

Editorial: Drug Repositioning: Current Advances and Future Perspectives
por: Nishimura, Yuhei, et al.
Publicado: (2018)

Current Evidence and Future Directions of Berberine Intervention in Depression
por: Zhu, Wen-Qian, et al.
Publicado: (2022)

Current and future therapies to treat impaired awareness of hypoglycemia
por: Macon, Erica L., et al.
Publicado: (2023)

Small Molecule Palmatine Targeting Musashi-2 in Colorectal Cancer
por: Zhang, Xue, et al.
Publicado: (2022)

An Overview of Strobilurin Fungicide Degradation:Current Status and Future Perspective
por: Feng, Yanmei, et al.
Publicado: (2020)

Prediction of Potential Small Molecule-Associated MicroRNAs Using Graphlet Interaction
por: Guan, Na-Na, et al.
Publicado: (2018)

Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status
por: Downton, Teesha, et al.
Publicado: (2022)

Evidence for Effective Multiple K(+)-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V(2) Receptor
por: Lu, Te-Ling, et al.
Publicado: (2019)

Platelet-activating factor receptor antagonists of natural origin for acute ischemic stroke: a systematic review of current evidence
por: Li, Tingting, et al.
Publicado: (2022)

Single-Molecule Plasmon Sensing: Current Status and Future Prospects
por: Taylor, Adam B., et al.
Publicado: (2017)

Cost-Utility Analysis: Current Methodological Issues and Future Perspectives
por: Nuijten, Mark J. C., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hefgg0lnve1pdr76f1b4sd462r